RT @farma_gregorio: Guía de implementación del genotipo de CYP2D6 en la clínica de la atomoxetina. https://t.co/Ld7I1wqCKm
Guía de implementación del genotipo de CYP2D6 en la clínica de la atomoxetina. https://t.co/Ld7I1wqCKm
RT @cpicpgx: Our new guideline for #atomoxetine and #CYP2D6 has just been published in @ASCPT_ClinPharm https://t.co/phklL9U408 #pharmacoge…
See our blog for a summary https://t.co/fOcCOEz4dY & access the guideline annotation here https://t.co/Dmc4eDjmi8 #pharmacogenomics #ADHD
RT @cpicpgx: Our new guideline for #atomoxetine and #CYP2D6 has just been published in @ASCPT_ClinPharm https://t.co/phklL9U408 #pharmacoge…
RT @cpicpgx: Our new guideline for #atomoxetine and #CYP2D6 has just been published in @ASCPT_ClinPharm https://t.co/phklL9U408 #pharmacoge…
RT @cpicpgx: Our new guideline for #atomoxetine and #CYP2D6 has just been published in @ASCPT_ClinPharm https://t.co/phklL9U408 #pharmacoge…
Our new guideline for #atomoxetine and #CYP2D6 has just been published in @ASCPT_ClinPharm https://t.co/phklL9U408 #pharmacogenomics #ADHD #PrecisionMedicine
Check it out: Clinical Pharmacogenetics Implementation Consortium (@cpicpgx) Guideline for CYP2D6 Genotype and Atomoxetine Therapy. https://t.co/oMudsQnNec